Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues
Jérémie Rouger, Hélène Jakobczyk, Lydie Debaize, et al.
Blood Reviews (2019) Vol. 36, pp. 40-56
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
Leila Amini, Sara Silbert, Shannon L. Maude, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 342-355
Closed Access | Times Cited: 208
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Yan Zhao, Cheng Xing, Yating Deng, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 234-251
Open Access | Times Cited: 53
Challenges and strategies associated with CAR-T cell therapy in blood malignancies
Zhaoyun Liu, Wenhui Lei, Hao Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
A narrative review of central nervous system involvement in acute leukemias
Dalma Deak, Nicolae Gorcea-Andronic, Valentina Sas, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 1, pp. 68-68
Open Access | Times Cited: 52
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy
Elizabeth M. Holland, Bonnie Yates, Alexander Ling, et al.
Blood Advances (2021) Vol. 6, Iss. 7, pp. 2167-2182
Open Access | Times Cited: 41
Targeting chemokines for acute lymphoblastic leukemia therapy
Zixi Hong, Zimeng Wei, Tian Xie, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
Rahele Khademi, Hossein Malekzadeh, Sara Bahrami, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3466-3466
Open Access | Times Cited: 14
A Review of Acute Lymphocytic Leukemia (ALL) in the Pediatric Population: Evaluating Current Trends and Changes in Guidelines in the Past Decade
Queen L Ekpa, Prince C Akahara, Alexis M Anderson, et al.
Cureus (2023)
Open Access | Times Cited: 13
Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches
Tianning Gu, Meng Zhu, He Huang, et al.
Journal of Zhejiang University SCIENCE B (2022) Vol. 23, Iss. 10, pp. 793-811
Open Access | Times Cited: 21
Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression
Georgia Tsaouli, Elisabetta Ferretti, Diana Bellavia, et al.
Journal of Immunology Research (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 32
Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance
Leslie M. Jonart, Maryam Ebadi, Patrick Basile, et al.
Haematologica (2019) Vol. 105, Iss. 8, pp. 2130-2140
Open Access | Times Cited: 27
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
George Mo, Hao‐Wei Wang, Aimee C. Talleur, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001563-e001563
Open Access | Times Cited: 26
Emerging roles of circRNAs in leukemia and the clinical prospects: An update
Wei Deng, Rong Chao, Shengdong Zhu
Immunity Inflammation and Disease (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 14
CAR T cells better than BiTEs
John C. Molina, Nirali N. Shah
Blood Advances (2021) Vol. 5, Iss. 2, pp. 602-606
Open Access | Times Cited: 19
Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease
Valentín Ortiz‐Maldonado, Anna Alonso‐Saladrigues, Marta Español‐Rego, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 6, pp. 731-739
Closed Access | Times Cited: 13
Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia
Sandeep Pandey, Ranjana Singh, Nimra Habib, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 4, pp. 1121-1134
Open Access | Times Cited: 2
Approach to the Adult Acute Lymphoblastic Leukemia Patient
Valentina Sas, Vlad Moisoiu, Patric Teodorescu, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 8, pp. 1175-1175
Open Access | Times Cited: 22
CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity
Kam Tong Leung, Chi Zhang, Kathy Yuen Yee Chan, et al.
Leukemia (2019) Vol. 34, Iss. 3, pp. 709-720
Closed Access | Times Cited: 21
<p>The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia</p>
Shan Wang, Xiaojiao Wang, Sha Liu, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 6583-6591
Open Access | Times Cited: 19
Purple sweet potato anthocyanins elicit calcium overload-induced cell death by inhibiting the calcium-binding protein S100A4 in acute lymphoblastic leukemia
Ling Guo, Jing Liu, Yang You, et al.
Food Bioscience (2021) Vol. 42, pp. 101214-101214
Closed Access | Times Cited: 16
<p>Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia</p>
Dimitri J. Maamari, Habib El‐Khoury, Omran Saifi, et al.
Pharmacogenomics and Personalized Medicine (2020) Vol. Volume 13, pp. 295-317
Open Access | Times Cited: 13
Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP-1) in the clinical progression of pediatric acute lymphoblastic leukemia
Maha Saleh, Mohammed N. A. Khalil, Mona S. Abdellateif, et al.
Hematology (2021) Vol. 26, Iss. 1, pp. 758-768
Open Access | Times Cited: 12
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment
Tessa Skroblyn, Jara J. Joedicke, Madlen Pfau, et al.
The Journal of Pathology (2022) Vol. 258, Iss. 1, pp. 12-25
Open Access | Times Cited: 8
Calcicoptosis Induced by Purple Sweet Potato Anthocyanins through the Nonosmotic Regulation of the NFAT5/S100A4‐S100A9 Pathway in Acute Lymphoblastic Leukemia
Ling Guo, Yanling Jin, Yang You, et al.
Chemistry & Biodiversity (2022) Vol. 19, Iss. 9
Closed Access | Times Cited: 8
Novel bioactive hybrid Celecoxib-HDAC Inhibitor, induces apoptosis in human acute lymphoblastic leukemia cells
Jing Liu, Li Zhang, Ling Guo, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 75, pp. 117085-117085
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top